
Headwinds from legacy brands, especially Dr. Tobias due to Amazon’s A10 algorithm changes, are being actively addressed and showing early signs of stabilization. Marketing is now more centralized with the new CMO. Irwin execution is tracking well: Amazon revenue hit ~$900k in April (up from nothing in early Oct) with subscriber count surging past 5,700. MusclePharm is also gaining traction, with new SKUs launching into 700–800 Kroger stores nationwide in June. Short-term headwind, but management is executing and the company will emerge stronger with lessons learned and a sharper strategy imo.
English











